Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Keohan

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Seminars in Oncology|October 31, 1997
Chemotherapy for advanced sarcoma: therapeutic decisions and modalitiesM L Keohan, R N Taub
Investigational New Drugs|January 1, 1997
A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcomaM L Keohan, M R Grever, S P Balcerzak, et al.
Current Treatment Options in Oncology|June 12, 2002
Peritoneal mesotheliomaR N Taub, M L Keohan, J C Chabot, et al.
The Journal of Experimental Medicine|June 1, 1985
Phenotype of recovering lymphoid cell populations after marrow transplantationK A Ault, J H Antin, D Ginsburg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2012
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumorsM A Dickson, S H Okuno, M L Keohan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Gemcitabine for relapsed or resistant lymphomaD G Savage, S A Rule, M Tighe, et al.
Investigational New Drugs|April 28, 2012
A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcomaChristopher W Ryan, Chacon Matias, Mark Agulnik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcomaM A Dickson, M R Mahoney, W D Tap, et al.
British Journal of Cancer|October 10, 2013
High-risk features in radiation-associated breast angiosarcomasS P D'Angelo, C R Antonescu, D Kuk, et al.
Sarcoma|June 18, 2016
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine LeiomyosarcomaA N Shoushtari, J Landa, D Kuk, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|October 31, 1997
Chemotherapy for advanced sarcoma: therapeutic decisions and modalitiesM L Keohan, R N Taub
Investigational New Drugs|January 1, 1997
A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcomaM L Keohan, M R Grever, S P Balcerzak, et al.
Current Treatment Options in Oncology|June 12, 2002
Peritoneal mesotheliomaR N Taub, M L Keohan, J C Chabot, et al.
The Journal of Experimental Medicine|June 1, 1985
Phenotype of recovering lymphoid cell populations after marrow transplantationK A Ault, J H Antin, D Ginsburg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2012
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumorsM A Dickson, S H Okuno, M L Keohan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Gemcitabine for relapsed or resistant lymphomaD G Savage, S A Rule, M Tighe, et al.
Investigational New Drugs|April 28, 2012
A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcomaChristopher W Ryan, Chacon Matias, Mark Agulnik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcomaM A Dickson, M R Mahoney, W D Tap, et al.
British Journal of Cancer|October 10, 2013
High-risk features in radiation-associated breast angiosarcomasS P D'Angelo, C R Antonescu, D Kuk, et al.
Sarcoma|June 18, 2016
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine LeiomyosarcomaA N Shoushtari, J Landa, D Kuk, et al.
Pageof 2